SILO 0.96 (-8.57%)
US82711P2011BiotechnologyBiotechnology

SILO Pharma (SILO) Stock Highlights

0.96 | -8.57%
2024-06-19 05:54:48
SILO Pharma Inc is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. The company is engaged in developing innovative solutions to address a variety of underserved conditions which includes Alzheimers; Parkinsons; Multiple Sclerosis (MS); Rheumatoid Arthritis (RA); and Stress-Induced Psychiatric Disorders.

Statistics

Range Today
0.96 1.07
Volume Today 132.7K
Range 1 Year
1.04 3.05
Volume 1 Year 49.04M
Range 3 Year
0.17 14.9
Volume 3 Year 103.93M
Range 10 Year
0.17 24.75
Volume 10 Year 104.4M

Highlights

Market Capitalization 4.06M (micro)
Floating Shares 2.58M
Current Price 0.96
Price To Earnings -1.08
Price To Revenue -50.77
Price To Book 0.59
Earnings Per Share -1.17
Payout Ratio 0%

Performance

Latest -8.57%
1 Month -46.67%
3 Months -44.19%
6 Months -36.42%
1 Year -55.96%
3 Years -93.47%
5 Years -94.95%
10 Years -94.95%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.